Nkarta Inc. (NKTX) Social Stream



Nkarta Inc. (NKTX): $13.76

-0.21 (-1.50%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NKTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 400

in industry

Nkarta Inc (NKTX) Price Targets From Analysts

Use the tables below to see what analysts covering Nkarta Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-10 4 $77 $71 $74.333 $11.42 550.9%
2021-11-16 4 $75 $71 $72.333 $11.42 533.39%
2021-11-18 5 $75 $50 $66.75 $11.42 484.5%
2022-03-18 7 $71 $17 $43 $11.42 276.53%
2022-03-29 8 $71 $17 $43 $11.42 276.53%

The Trend in the Analyst Price Target


Over the past 34 weeks, NKTX's average price target has gone down $32.4.

NKTX reports an average of 236.44% for its upside potential over the past 50 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-26 4 81 70 77.250 29.41 162.67%
2021-08-04 5 81 70 75.400 33.75 123.41%
2021-09-08 5 81 70 74.800 28.27 164.59%
2021-10-10 4 77 71 74.333 18.10 310.68%
2022-03-18 7 71 25 48.200 12.04 300.33%

NKTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.13 7 1 0 0 0 8

The Trend in the Broker Recommendations


NKTX's average broker recommendation rating improved by 0.4 over the prior 151 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, Nkarta Inc's upside potential (average analyst target price relative to current price) is greater than 854.12% of them.
  • NKTX has a lower variance in analysts' estimates than -331.89% of Pharmaceutical Products stocks.
  • Nkarta Inc's average analyst price target is greater than 663% of Pharmaceutical Products stocks.
  • NKTX has a greater number of analysts covering the stock than 442.5% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, NGM, NBRV, and MYOV are the three stocks most similar to Nkarta Inc regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding NKTX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4063 seconds.